Using cell mass to determine response to treatment: A possible cure?
Prospects of treating CLL and their complications
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
MRD negativity and its role as a predictor for CLL patient responses
What we can learn about treating CLL from research on other cancers